RegulatoryJun 15, 2026, 11:16 AM
Genmab Files Form 6-K, Includes Articles of Association
AI Summary
Genmab A/S filed a Form 6-K with the U.S. Securities and Exchange Commission on June 15, 2026. This report is incorporated by reference into several of the company's existing Form S-8 registration statements. The filing includes the company's Articles of Association as Exhibit 3.1.
Key Highlights
- Genmab A/S filed a Form 6-K with the SEC on June 15, 2026.
- The report is incorporated by reference into multiple Form S-8 registration statements.
- Exhibit 3.1 of the filing includes the company's Articles of Association.
- The report was signed by Anthony Pagano, Executive Vice President & Chief Financial Officer.
Price Impact
More from GMAB